Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Experience Study of the Sientra 207 High-Strength Cohesive Plus (HSC+) Breast Implants in Primary and Revision Augmentation Participants

NCT02905617 is registered in ClinicalTrials.gov with Tiger Biosciences, LLC. as lead sponsor.

NCT NCT02905617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02905617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Experience Study of the Sientra 207 High-Strength Cohesive Plus (HSC+) Breast Implants in Primary and Revision Augmentation Participants
Lead sponsor
Tiger Biosciences, LLC.
Phase
Observational
Overall status
Terminated
Start date
August 31, 2016
Completion date
July 15, 2020
Enrollment
113 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast augmentation, breast revision-augmentation